Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Pharmaceutical Medicine|December 16, 2025
Publicly Available Clinical Trial Safety Data: Review and a Call for Standardization and Improved Reporting PracticesBarbara A Hendrickson, Cynthia McShea, Tarek A Hammad, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2020
The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studiesChristine A Radawski, Tarek A Hammad, Susan Colilla, et al.
Drug Safety|October 17, 2025
Navigating Non-interventional Post-authorization Studies in East Asia: Regulatory Challenges, Opportunities, and Future DirectionsJami Peters, Ayad K Ali, Maria Moitinho de Almeida, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 2, 2020
Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenterTarek A Hammad, Melanie Parikh, Nour Tashtish, et al.
JACC. Cardiovascular Interventions|August 22, 2015
The Effect of Post-Exercise Ankle-Brachial Index on Lower Extremity RevascularizationTarek A Hammad, Jason A Strefling, Paul R Zellers, et al.
Vascular Medicine (London, England)|May 30, 2023
Immunologic profiles in patients with chronic limb-threatening ischemia undergoing endovascular revascularizationJun Li, Shilpkumar Arora, Heather Wheat, et al.
The Oncologist|May 27, 2018
Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to ActionTomas G Neilan, Mace L Rothenberg, Laleh Amiri-Kordestani, et al.
Archives of Women'S Mental Health|May 15, 2016
Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration's Mini-Sentinel programSusan E Andrade, Marsha E Reichman, Katrina Mott, et al.
Vascular Medicine (London, England)|January 23, 2016
The association between ischemic and jeopardized myocardia and all-cause mortality in patients with peripheral artery diseaseTarek A Hammad, Rayan Yousefzai, Sridhar Venkatachalam, et al.
Frontiers in Pharmacology|September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to actionRosanne Janssens, Liese Barbier, Mireille Muller, et al.
Pageof 8